Introduction to Part
Second, although we both believe in the power of the free market to drive innovation and progress in healthcare, Prof. Santoro believes that stronger government regulation of the pharmaceutical industry is desirable and inevitable because he believes that the dictates of the market too often drive pharmaceutical companies to maximize their profits in a manner that fails to deploy social resources optimally to provide the best healthcare for citizens. Dr. Gorrie, by contrast, believes that marketplace forces can more effectively address issues in the system than can the controlling hand of government.
Our differing perspectives are, in part, based upon our different experiences -Dr. Gorrie has spent his career at Johnson & Johnson in a number of roles, most recently as the Corporate Vice President of Government Affairs; Prof. Santoro has devoted his academic career to bringing accountability to multinational corporations for global social issues such as human rights and the environment.
Our differences, philosophical and otherwise, are real and significant; however, we both believe that choice is the lynchpin of effective healthcare and that all people should have access to affordable products and services that will save, enhance, improve, and prolong their lives, a mandate that certainly extends to people suffering from global pandemics. Most importantly, we both believe that knowledge best emerges from dialogue and listening to diverse viewpoints. This book offers multiple perspectives about the highly charged ideological issues the industry faces today. Written by leading experts in their respective fields, the essays comprising this book are not biased toward one particular point of view (either pro-business or anti-corporate). We both highly value the opportunity to engage in public discourse about business and ethics, and, in particular, to talk about the complex ethical issues inherent in medicine and healthcare. We believe that reasoned discussion will open channels of communication, lead to better understanding, and ultimately result in progressive change.
Another area of agreement between the editors is that future healthcare innovations and solutions will arise from long-term partnerships. Too much of the debate thus far has focused on confrontation (e.g., advocates vs. industry). Although such conflicts are inevitable given the diversity of the material interests involved, in order for
